Article
The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.
Pathology, research and practice - 1 May 2018
Li Rui-Dong, Tang Yan-Hua, Wang Hui-Li, Yang Dong, Sun Li-Jun, Li Wei
Abstract excerpt
OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most lethal human malignancies in China, and the genetic link of hepatocarcinogenesis remains to be defined. Thus, we explored the role of SET and myeloid translocation protein 8, Nervy, and DEAF1 (MYND) domain containing protein 3 (SMYD3) gene polymorphism on risk and prognosis of HCC. METHODS: A total of 236 patients with HCC who received treatment in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
